MET and renal cell carcinoma: Gibney et al. evaluated c-Met expression as a prognostic marker in 317 patients with RCC and found that high c-Met expression was an independent predictor of survival (multivariate HR = 1.013 [95% CI: 1.002–1.023], P = 0.015) [34].